SLU-PP-332: Research Guide to the ERRα Exercise Mimetic

SLU-PP-332 is an orally active ERRα agonist that has drawn significant attention in metabolic and endurance research as a so-called “exercise mimetic”. This guide covers what the compound is, how its receptor mechanism differs from stimulants and hormone-based compounds, what published preclinical work reports, and what specification research-grade material should meet. Written for research context only – no human use protocols are provided.

What is SLU-PP-332?

SLU-PP-332 is a small-molecule pan-agonist of the estrogen-related receptors, with the strongest affinity for ERRα. It was developed at Saint Louis University – the “SLU” in the name – as a research tool for studying how mitochondrial and oxidative metabolism can be activated pharmacologically.

Despite the receptor family name, it has nothing to do with estrogen signalling. Estrogen-related receptors are orphan nuclear receptors: structurally similar to estrogen receptors, but they do not bind estrogen and operate on an entirely separate pathway governing energy metabolism.

It is supplied as an orally active compound in capsule format, which is one reason it appears so frequently in extended study designs – no reconstitution, no injection, minimal handling variance across a multi-week protocol.

Mechanism: ERRα activation

ERRα is a master regulator of oxidative metabolism. It works alongside PGC-1α, the coactivator that is upregulated by endurance exercise, to control the genes that govern how cells produce and consume energy. Activating ERRα pharmacologically engages that same downstream programme:

• Mitochondrial biogenesis — increased transcription of genes driving mitochondrial density in muscle tissue
• Fatty acid oxidation — a shift in substrate preference toward fat as a fuel source
• Oxidative phosphorylation — upregulation of the electron transport chain machinery
• Fibre-type signalling — markers associated with a shift toward oxidative, fatigue-resistant muscle fibres

Why the target matters

Most compounds studied for endurance work either upstream of metabolism (stimulants raising catecholamines) or downstream of it (substrate supplementation). ERRα sits at the transcriptional level – it changes which genes are expressed, not just how hard the system is being driven. That is the reason the target attracted attention independently of any performance narrative.

Why it is called an exercise mimetic

The label comes from the observation that ERRα activation engages a transcriptional programme overlapping with the adaptation seen after endurance training. In published rodent work, treated animals showed markers consistent with aerobic conditioning without a corresponding change in training load.

The term is a useful shorthand, but it deserves qualification. “Exercise mimetic” describes overlap in a specific gene expression programme – not a replacement for the cardiovascular, neuromuscular and skeletal adaptations that physical training produces. Research framing it as such is describing a molecular pathway, not an equivalence.

Research overview

The table summarises the principal areas SLU-PP-332 has been investigated in. These are observations from published preclinical literature, not outcomes to be expected outside a controlled research setting.

The evidence base needs to be read for what it is. SLU-PP-332 is a relatively recent research compound; the published data is preclinical, predominantly rodent, and there are no completed human clinical trials. Long-term safety in any species is not characterised. Suppliers presenting it as a proven performance product are going well beyond the literature.

How SLU-PP-332 differs from stimulants

For a compound acting through the growth hormone axis instead, see our MK-677 research guide. For metabolic research through incretin receptors, see our Retatrutide 10 mg research guide.

SLU-PP-332 specification

The SLU-PP-332 supplied by Peptide Revolution is intended strictly for laboratory research. Each unit is documented so a study can be traced back to a specific batch.

Handling & storage

Capsule-format compounds are considerably more forgiving than lyophilized peptides, but storage still determines how long a batch holds specification.

• Temperature — store in a cool, dry place; avoid repeated heat cycling
• Light — keep in the original opaque container, away from direct sunlight
• Humidity — moisture is the primary degradation risk for capsule formats
• Documentation — log the batch number and receipt date at the start of any protocol

Frequently asked questions

What is SLU-PP-332 used for in research?

Published preclinical work investigates SLU-PP-332 in endurance capacity, mitochondrial biogenesis, fatty acid oxidation and metabolic markers. It is a research compound, not an approved treatment or supplement.

Is SLU-PP-332 a SARM or a peptide?

Neither. It is a small-molecule agonist of ERRα, a nuclear receptor governing oxidative metabolism. SARMs act on the androgen receptor and peptides are amino acid chains – SLU-PP-332 belongs to a different class entirely.

Does SLU-PP-332 affect hormones?

Despite the estrogen-related receptor name, ERRα does not bind estrogen and is not part of the sex hormone axis. Published work describes effects on metabolic gene expression rather than hormonal suppression or stimulation.

What purity should research-grade SLU-PP-332 have?

≥99% by HPLC, confirmed on a certificate of analysis referencing the batch number on the unit you received. A generic COA not tied to your batch provides no meaningful assurance.

How should SLU-PP-332 capsules be stored?

In a cool, dry, dark place in the original sealed container. Humidity is the main limiting factor; stored correctly, capsule-format material remains stable well beyond typical study durations.

Is SLU-PP-332 approved for human use?

No. SLU-PP-332 is not an approved medicinal product or dietary supplement in the EU and is not authorised for human or veterinary use. It is supplied strictly for in-vitro laboratory research.

Research use disclaimer

All products supplied by Peptide Revolution are intended strictly for in-vitro laboratory research and analytical purposes. They are not medicinal products, food supplements, cosmetics or veterinary preparations, and they are not approved for the diagnosis, treatment or prevention of any condition.

By purchasing, the customer confirms they are a qualified professional or research institution and that the material will be handled in accordance with applicable laws and good laboratory practice. This article summarises published scientific literature for informational purposes and does not constitute medical advice or a usage recommendation.